Concepedia

Melissa Leija‐Salazar

ML

4

Publications

160

Citations

4

H-Index

2019

Active since

Affiliations

University College London(Current)

National Hospital for Neurology and Neurosurgery

Melissa Leija‐Salazar is an author at University College London specializing in medicine, pharmacology, and molecular pharmacology.

ORCID

Top concepts

Publications per year

2019–2020

4

Publications

4

Evaluation of the detection of <i>GBA</i> missense mutations and other variants using the Oxford Nanopore MinION

Melissa Leija‐Salazar, Fritz J. Sedlazeck, Marco Toffoli et al. · Molecular Genetics & Genomic Medicine · 2019 · 90 citations · Full text

Investigation of somatic CNVs in brains of synucleinopathy cases using targeted SNCA analysis and single cell sequencing

Diego Pérez‐Rodríguez, Maria Kalyva, Melissa Leija‐Salazar et al. · Acta Neuropathologica Communications · 2019 · 50 citations · Full text

Arachidonyl-2′-chloroethylamide (ACEA), a synthetic agonist of cannabinoid receptor, increases CB1R gene expression and reduces dyskinesias in a rat model of Parkinson's disease

Melissa Leija‐Salazar, Mario Bermúdez de León, Azucena González-Horta et al. · Pharmacology Biochemistry and Behavior · 2020 · 10 citations

, , +13

Investigation of Somatic Mutations in Human Brains Targeting Genes Associated With Parkinson's Disease

Melissa Leija‐Salazar, Alan Pittman, Katya Mokretar et al. · Frontiers in Neurology · 2020 · 10 citations · Full text

Rows per page

1–4 of 4